Funding for this research was provided by:
Niuvanniemi Hospital (330104)
Text and Data Mining valid from 2018-11-06
Received: 26 February 2018
Accepted: 24 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: The permission for the study was granted by the Board of Niuvanniemi Hospital and by the Finnish National Institute for Health and Welfare. Consents to participate was not obtained from participants (register-based study).
: Not applicable.
: Kristiina Kivimies, Eila Repo-Tiihonen, and Hannu Kautiainen report no conflicts of interest. Jari Tiihonen reports serving as a consultant to European Medicines Agency (EMA) and Finnish Medicines Agency (Fimea); receiving lecture fees from Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka; grants from from Stanley Foundation and Sigrid Jusélius Foundation; and participating in research projects funded by Janssen-Cilag and Eli Lilly with grants paid to Karolinska Institutet.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.